Pharmacology & ToxicologybioRxivPreprint
DRP1 inhibition confers cardioprotection against doxorubicin while preserving anticancer efficacy
Yali Deng, Sebastian Bass-Stringer, Simon T. Bond…·Shiang Yong Lim
This paper shows DRP1 inhibition reduces doxorubicin-induced cardiotoxicity while maintaining its anticancer effects in multiple cancer models.